Benvitimod

本维莫德

Report date: 2026/04/23 20:00:25
NMEFirst In Class

Base Information

Drug NameBenvitimod
Drug Alias Name苯烯莫德Tapinarof欣比克XinbikeSymbiox +[17] 
ClassificationSmall molecules
Mechanisms of ActionCytokine receptors antagonistsAryl hydrocarbon receptor agonists
TargetsCytokine receptorsAryl hydrocarbon receptor
Therapy Area/IndicationsPlaque psoriasisPsoriasisVitiligo +[10] 
Global Approved IndicationsPlaque psoriasisPsoriasisDermatitis, Atopic
Approved Indications in ChinaPsoriasis
Original Approved Country/TerritoryMainland China
Original Approved Date2019/05/29
Country/TerritoryCanadaUnited StatesGermany +[5] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesWelichem Biotech Inc
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesSol-Gel Technologies LtdOrganon Canada IncShanghai Zedman Pharmaceutical Technology Co Ltd +[10] 
Inactive CompaniesStiefel LaboratoriesShenzhen Celestial Pharmaceuticals LtdGlaxosmithkline Plc +[9] 
Active IndicationsPlaque psoriasisPsoriasisVitiligo +[10] 
Inactive IndicationsN/A

Other Information

ATC CodeD05
Related LinksWikipediaDrugBank